Swedencare AB’s complete annual report for 2022 is attached to this press release and is available at https://swedencare.com/investors/. The english version of this annual report will be published at a later date.
Swedencare AB’s complete annual report for 2022 is attached to this press release and is available at https://swedencare.com/investors/. The english version of this annual report will be published at a later date.
For more information, please contact:
Håkan Lagerberg, CEO Swedencare
Phone: +46 (0)73 517 01 70
Email: [email protected]
Jenny Graflind, CFO Swedencare
Phone: +46 (0)73 944 85 54
Email: [email protected]
FNCA is the Certified Adviser of the Company
Please visit the Company homepage www.swedencare.com
About Swedencare
Swedencare, a listed company on NASDAQ First North Growth Market, specializes in pet healthcare and produces, markets and sells premium products in the global and fast-growing market. The company has a wide range of strong brands and products within most therapy areas, including Animal Pharmaceuticals®, Nutravet®, NutriScience, Pet MD®, Stratford®, VetWELL®, NaturVet® as well as ProDen PlaqueOff® for oral health to dogs and cats. Swedencare’s headquarter is in Malmö, Sweden with subsidiaries located in nine countries with products sold in more than sixty countries. Swedencare’s sales have increased significantly over the last few years with strong margins and profits.
Tilaa uutiskirjeemme ja saat uusimmat uutiset, päivitykset ja sisältönostot suoraan sähköpostiisi.